Naimi, R. M., Hvistendahl, M. K., Thomassen, L. M., Johnsen, H., Christiansen, C. B., Holst, J. J., . . . Jeppesen, P. B. (2021). Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: An open-label pilot study. BMJ Open Gastroenterol.

Naimi, Rahim Mohammad, Mark Krogh Hvistendahl, Lise Margrete Thomassen, Hanna Johnsen, Charlotte Bayer Christiansen, Jens Juul Holst, Bolette Hartmann, ja Palle Bekker Jeppesen. "Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Patients With Short Bowel Syndrome and Colon in Continuity: An Open-label Pilot Study." BMJ Open Gastroenterol 2021.

Naimi, Rahim Mohammad, et al. "Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Patients With Short Bowel Syndrome and Colon in Continuity: An Open-label Pilot Study." BMJ Open Gastroenterol 2021.